Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
1(100.0%)
1Total
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05020210Unknown

Effect of Early Treatment With Sivelestat Sodium in ARDS Patients

Role: collaborator

NCT02681822Unknown

Multi-center Imaging Genetics Studies in China

Role: collaborator

NCT01379391Phase 4Unknown

Efficacy and Safety of rHuTPO on Platelet Engraftment After Allo-HSCT

Role: collaborator

All 3 trials loaded